Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-04-18 23:02 Tx date 2024-04-18 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
1,450,000 | |
Filed 2024-04-18 22:54 Tx date 2024-04-18 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,252
+8,500 vol $0.265 each |
4,330,512 | |
Filed 2024-04-18 22:54 Tx date 2024-04-16 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$560.00
+2,000 vol $0.28 each |
4,322,012 | |
Filed 2024-04-12 02:35 Tx date 2024-04-11 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,400
+5,000 vol $0.28 each |
4,320,012 | |
Filed 2024-03-11 18:09 Tx date 2024-03-08 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$450.00
+1,500 vol $0.30 each |
4,315,012 | |
Filed 2023-12-29 20:54 Tx date 2023-12-27 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$390.00
+1,500 vol $0.26 each |
4,313,512 | |
Filed 2023-12-22 20:36 Tx date 2023-12-22 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$360.00
+1,500 vol $0.24 each |
4,312,012 | |
Filed 2023-12-22 20:28 Tx date 2023-12-20 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,150
+5,000 vol $0.23 each |
4,310,512 | |
Filed 2023-12-17 21:10 Tx date 2023-12-15 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,325
+5,000 vol $0.265 each |
4,305,512 | |
Filed 2023-09-02 15:56 Tx date 2023-08-30 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$280.00
+1,000 vol $0.28 each |
4,300,512 | |
Filed 2023-08-07 19:43 Tx date 2023-08-03 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
$41,800
+220,000 vol $0.19 each |
4,299,512 | |
Filed 2023-08-07 19:41 Tx date 2023-08-03 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$-41,800
-220,000 vol $0.19 each |
642,088 | |
Filed 2023-08-07 19:24 Tx date 2023-08-03 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$292.50
+1,500 vol $0.195 each |
4,079,512 | |
Filed 2023-07-25 18:49 Tx date 2023-07-21 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,877
+16,500 vol $0.235 each |
4,078,012 | |
Filed 2023-06-23 16:30 Tx date 2023-06-21 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$630.00
+2,000 vol $0.315 each |
4,061,512 | |
Filed 2023-06-16 17:14 Tx date 2023-06-13 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$865.00
+2,500 vol $0.346 each |
4,059,512 | |
Filed 2023-04-22 17:37 Tx date 2023-04-21 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$367.50
+1,500 vol $0.245 each |
4,057,012 | |
Filed 2023-04-16 18:16 Tx date 2023-04-14 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$367.50
+1,500 vol $0.245 each |
4,055,512 | |
Filed 2023-03-24 16:30 Tx date 2023-03-24 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$322.50
+1,500 vol $0.215 each |
4,054,012 | |
Filed 2023-03-03 23:48 Tx date 2023-03-01 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$307.50
+1,500 vol $0.205 each |
4,052,512 | |
Filed 2023-02-27 23:07 Tx date 2023-02-27 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$307.50
+1,500 vol $0.205 each |
4,051,012 | |
Filed 2023-02-17 16:06 Tx date 2023-02-17 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$547.50
+3,000 vol $0.1825 each |
4,049,512 | |
Filed 2023-02-17 16:05 Tx date 2023-02-14 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$482.50
+2,500 vol $0.193 each |
4,046,512 | |
Filed 2023-02-03 16:08 Tx date 2023-02-03 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$496.50
+2,500 vol $0.1986 each |
4,044,012 | |
Filed 2023-01-31 16:16 Tx date 2023-01-31 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$462.00
+2,200 vol $0.21 each |
4,041,512 | |
Filed 2023-01-24 16:56 Tx date 2023-01-23 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$622.50
+3,000 vol $0.2075 each |
4,039,312 | |
Filed 2023-01-20 17:46 Tx date 2023-01-20 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$540.00
+2,500 vol $0.216 each |
4,036,312 | |
Filed 2023-01-10 17:52 Tx date 2023-01-10 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$345.00
+1,500 vol $0.23 each |
4,033,812 | |
Filed 2023-01-06 16:36 Tx date 2023-01-06 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,065
+5,000 vol $0.213 each |
4,032,312 | |
Filed 2023-01-01 13:36 Tx date 2022-12-30 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$220.00
+1,000 vol $0.22 each |
4,027,312 | |
Filed 2023-01-01 13:35 Tx date 2022-12-28 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$570.00
+3,000 vol $0.19 each |
4,026,312 | |
Filed 2022-12-03 00:12 Tx date 2022-12-01 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$200.00
+1,000 vol $0.20 each |
4,023,312 | |
Filed 2022-11-22 22:26 Tx date 2022-11-21 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$390.00
+2,000 vol $0.195 each |
4,022,312 | |
Filed 2022-11-11 16:22 Tx date 2022-11-11 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$350.00
+2,000 vol $0.175 each |
4,020,312 | |
Filed 2022-11-10 16:15 Tx date 2022-11-10 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$360.00
+2,000 vol $0.18 each |
4,018,312 | |
Filed 2022-11-01 18:02 Tx date 2022-11-01 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$292.50
+1,500 vol $0.195 each |
4,016,312 | |
Filed 2022-10-31 22:37 Tx date 2022-10-28 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$555.00
+3,000 vol $0.185 each |
4,014,812 | |
Filed 2022-10-19 17:25 Tx date 2022-10-19 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$684.95
+3,500 vol $0.1957 each |
4,011,812 | |
Filed 2022-10-16 19:11 Tx date 2022-10-14 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$-24,300
-135,000 vol $0.18 each |
862,088 | |
Filed 2022-10-16 19:08 Tx date 2022-10-14 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
$24,300
+135,000 vol $0.18 each |
4,008,312 | |
Filed 2022-10-16 19:04 Tx date 2022-10-14 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$925.00
+5,000 vol $0.185 each |
3,873,312 | |
Filed 2022-10-02 13:37 Tx date 2022-09-30 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,170
+6,000 vol $0.195 each |
3,868,312 | |
Filed 2022-09-27 16:11 Tx date 2022-09-27 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$195.00
+1,000 vol $0.195 each |
3,862,312 | |
Filed 2022-09-26 17:33 Tx date 2022-09-26 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$487.50
+2,500 vol $0.195 each |
3,861,312 | |
Filed 2022-09-23 16:16 Tx date 2022-09-20 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
$38,000
+200,000 vol $0.19 each |
3,857,812 | |
Filed 2022-09-23 16:14 Tx date 2022-09-20 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$-38,000
-200,000 vol $0.19 each |
997,088 | |
Filed 2022-09-23 16:09 Tx date 2022-09-23 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$200.00
+1,000 vol $0.20 each |
3,858,812 | |
Filed 2022-09-20 17:27 Tx date 2022-09-20 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,900
+10,000 vol $0.19 each |
3,657,812 | |
Filed 2022-09-16 16:08 Tx date 2022-09-16 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95.00
+500 vol $0.19 each |
3,647,812 | |
Filed 2022-09-16 16:07 Tx date 2022-09-15 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,000
+5,000 vol $0.20 each |
3,647,312 | |
Filed 2022-09-13 16:18 Tx date 2022-09-13 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$480.00
+2,000 vol $0.24 each |
3,642,312 | |
Filed 2022-09-12 16:16 Tx date 2022-09-12 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$265.00
+1,000 vol $0.265 each |
3,640,312 | |
Filed 2022-09-08 17:44 Tx date 2022-09-08 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$460.00
+2,000 vol $0.23 each |
3,639,312 | |
Filed 2022-09-06 16:15 Tx date 2022-09-06 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$382.50
+1,500 vol $0.255 each |
3,637,312 | |
Filed 2022-09-02 00:52 Tx date 2022-09-01 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$490.00
+2,000 vol $0.245 each |
3,635,812 | |
Filed 2022-08-29 00:57 Tx date 2022-08-26 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$135.00
+500 vol $0.27 each |
3,633,812 | |
Filed 2022-08-24 23:28 Tx date 2022-08-24 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$637.50
+2,500 vol $0.255 each |
3,633,312 | |
Filed 2022-08-22 16:11 Tx date 2022-08-22 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$600.00
+2,500 vol $0.24 each |
3,630,812 | |
Filed 2022-08-22 16:09 Tx date 2022-08-19 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,150
+5,000 vol $0.23 each |
3,628,312 | |
Filed 2022-08-10 16:49 Tx date 2022-08-10 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,000
+4,000 vol $0.25 each |
3,623,312 | |
Filed 2022-07-26 18:38 Tx date 2022-07-26 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$540.00
+2,000 vol $0.27 each |
3,619,312 | |
Filed 2022-07-18 16:01 Tx date 2022-07-18 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$280.00
+1,000 vol $0.28 each |
3,617,312 | |
Filed 2022-07-14 19:21 Tx date 2022-07-14 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
1,050,000 | |
Filed 2022-07-07 18:30 Tx date 2022-07-06 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,120
+4,000 vol $0.28 each |
3,616,312 | |
Filed 2022-07-01 00:51 Tx date 2022-06-30 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$550.00
+2,000 vol $0.275 each |
3,612,312 | |
Filed 2022-06-19 02:23 Tx date 2022-06-17 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,120
+4,000 vol $0.28 each |
3,610,312 | |
Filed 2022-06-19 02:21 Tx date 2022-06-14 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$37,500
+250,000 vol $0.15 each |
3,606,312 | |
Filed 2022-06-19 02:19 Tx date 2022-06-14 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-250,000 vol |
750,000 | |
Filed 2022-05-04 18:03 Tx date 2022-05-03 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$430.00
+2,000 vol $0.215 each |
3,354,312 | |
Filed 2022-05-03 11:40 Tx date 2022-05-02 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,300
+6,000 vol $0.2167 each |
3,352,312 | |
Filed 2022-04-27 11:59 Tx date 2022-04-26 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$630.00
+3,000 vol $0.21 each |
3,346,312 | |
Filed 2022-04-21 15:47 Tx date 2022-04-21 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$840.00
+4,000 vol $0.21 each |
3,343,312 | |
Filed 2022-04-13 16:15 Tx date 2022-04-13 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,025
+5,000 vol $0.205 each |
3,339,312 | |
Filed 2022-04-04 16:19 Tx date 2022-04-04 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,125
+5,000 vol $0.225 each |
3,334,312 | |
Filed 2022-03-07 14:26 Tx date 2022-03-07 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$690.00
+3,000 vol $0.23 each |
3,329,312 | |
Filed 2022-02-10 16:06 Tx date 2022-02-09 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$276.00
+1,200 vol $0.23 each |
3,326,312 | |
Filed 2022-01-12 17:03 Tx date 2022-01-12 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,115
+5,000 vol $0.223 each |
3,325,112 | |
Filed 2022-01-06 15:07 Tx date 2022-01-06 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,350
+10,000 vol $0.235 each |
3,320,112 | |
Filed 2021-12-27 13:27 Tx date 2021-12-24 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,350
+5,000 vol $0.27 each |
3,310,112 | |
Filed 2021-12-07 16:40 Tx date 2021-12-07 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$587.60
+2,000 vol $0.2938 each |
3,305,112 | |
Filed 2021-11-26 16:00 Tx date 2021-11-26 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,350
+5,000 vol $0.27 each |
3,303,112 | |
Filed 2021-11-25 13:18 Tx date 2021-11-24 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,325
+5,000 vol $0.265 each |
3,298,112 | |
Filed 2021-11-16 18:06 Tx date 2021-11-16 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,150
+5,000 vol $0.23 each |
3,293,112 | |
Filed 2021-11-15 22:40 Tx date 2021-11-15 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,860
+13,000 vol $0.22 each |
3,288,112 | |
Filed 2021-11-11 16:02 Tx date 2021-11-11 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,375
+10,000 vol $0.2375 each |
3,275,112 | |
Filed 2021-11-10 17:25 Tx date 2021-11-10 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,375
+10,000 vol $0.2375 each |
3,265,112 | |
Filed 2021-11-05 19:23 Tx date 2021-11-05 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$612.50
+2,500 vol $0.245 each |
3,255,112 | |
Filed 2021-11-01 16:05 Tx date 2021-11-01 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,365
+6,000 vol $0.2275 each |
3,252,612 | |
Filed 2021-10-25 00:10 Tx date 2021-10-22 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,087
+5,000 vol $0.2175 each |
3,246,612 | |
Filed 2021-10-20 18:50 Tx date 2021-10-19 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$230.00
+1,000 vol $0.23 each |
3,241,612 | |
Filed 2021-10-15 17:12 Tx date 2021-10-15 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,050
+5,000 vol $0.21 each |
3,240,612 | |
Filed 2021-10-13 16:21 Tx date 2021-10-13 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$547.50
+3,000 vol $0.1825 each |
3,235,612 | |
Filed 2021-10-08 14:16 Tx date 2021-10-08 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$385.00
+2,000 vol $0.1925 each |
3,232,612 | |
Filed 2021-10-07 16:18 Tx date 2021-10-07 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,000
+20,000 vol $0.20 each |
3,230,612 | |
Filed 2021-10-05 17:32 Tx date 2021-10-05 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,825
+10,000 vol $0.1825 each |
3,210,612 | |
Filed 2021-09-29 16:00 Tx date 2021-09-29 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$950.00
+5,000 vol $0.19 each |
3,200,612 | |
Filed 2021-09-24 16:28 Tx date 2021-09-24 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,451
+30,000 vol $0.1817 each |
3,195,612 | |
Filed 2021-09-23 17:10 Tx date 2021-09-23 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,805
+9,500 vol $0.19 each |
3,165,612 | |
Filed 2021-09-22 15:47 Tx date 2021-09-22 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$950.00
+5,000 vol $0.19 each |
3,156,112 | |
Filed 2021-09-15 21:17 Tx date 2021-09-14 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
$210,361
+1,137,088 vol $0.185 each |
3,145,112 | |
Filed 2021-09-15 21:14 Tx date 2021-09-14 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$-210,361.28
-1,137,088 vol $0.185 each |
1,197,088 | |
Filed 2021-09-15 21:10 Tx date 2021-09-15 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,140
+6,000 vol $0.19 each |
3,151,112 | |
Filed 2021-09-09 16:14 Tx date 2021-09-09 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$950.00
+5,000 vol $0.19 each |
2,008,024 | |
Filed 2021-08-31 13:16 Tx date 2021-08-30 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$570.00
+3,000 vol $0.19 each |
2,003,024 | |
Filed 2021-08-12 16:52 Tx date 2021-08-12 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,760
+8,000 vol $0.22 each |
2,000,024 | |
Filed 2021-08-05 14:39 Tx date 2021-08-04 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,000
+5,000 vol $0.20 each |
1,992,024 | |
Filed 2021-07-29 15:16 Tx date 2021-07-28 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$600.00
+3,000 vol $0.20 each |
1,987,024 | |
Filed 2021-07-27 18:33 Tx date 2021-07-27 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,000
+20,000 vol $0.20 each |
1,984,024 | |
Filed 2021-07-13 17:01 Tx date 2021-07-13 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,600
+20,000 vol $0.23 each |
1,964,024 | |
Filed 2021-07-12 21:35 Tx date 2021-07-12 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$705.00
+3,000 vol $0.235 each |
1,944,024 | |
Filed 2021-07-05 16:43 Tx date 2021-07-05 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$288.00
+1,200 vol $0.24 each |
1,941,024 | |
Filed 2021-06-29 23:59 Tx date 2021-06-29 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,350
+10,000 vol $0.235 each |
1,939,824 | |
Filed 2021-06-25 14:40 Tx date 2021-06-25 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,900
+30,000 vol $0.23 each |
1,929,824 | |
Filed 2021-06-24 22:36 Tx date 2021-06-24 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,945
+30,000 vol $0.2315 each |
1,899,824 | |
Filed 2021-06-22 17:27 Tx date 2021-06-22 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,800
+30,000 vol $0.26 each |
1,869,824 | |
Filed 2021-06-10 19:24 Tx date 2021-06-10 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$370.00
+1,000 vol $0.37 each |
1,839,824 | |
Filed 2021-06-09 14:30 Tx date 2021-06-08 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,480
+4,000 vol $0.37 each |
1,838,824 | |
Filed 2021-06-04 16:08 Tx date 2021-06-04 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$395.00
+1,000 vol $0.395 each |
1,834,824 | |
Filed 2021-05-19 13:02 Tx date 2021-05-18 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$370.00
+1,000 vol $0.37 each |
1,833,824 | |
Filed 2021-05-17 17:55 Tx date 2021-05-17 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$350.00
+1,000 vol $0.35 each |
1,832,824 | |
Filed 2021-05-14 16:31 Tx date 2021-05-14 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,330
+9,000 vol $0.37 each |
1,831,824 | |
Filed 2021-05-14 15:49 Tx date 2021-05-13 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,100
+15,000 vol $0.34 each |
1,822,824 | |
Filed 2021-04-18 16:44 Tx date 2021-04-16 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$100,000
+500,000 vol $0.20 each |
1,807,824 | |
Filed 2021-04-18 16:41 Tx date 2021-04-16 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
-500,000 vol |
0 | |
Filed 2021-04-09 16:06 Tx date 2021-04-06 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
$10,000
+22,728 vol $0.44 each |
1,307,824 | |
Filed 2021-04-09 16:03 Tx date 2021-04-06 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$-10,000.32
-22,728 vol $0.44 each |
2,334,176 | |
Filed 2021-02-25 16:26 Tx date 2021-02-25 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,540
+7,000 vol $0.22 each |
1,285,096 | |
Filed 2021-02-18 16:34 Tx date 2021-02-18 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,960
+18,000 vol $0.22 each |
1,278,096 | |
Filed 2021-02-16 15:10 Tx date 2021-02-16 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,075
+5,000 vol $0.215 each |
1,260,096 | |
Filed 2021-02-03 16:16 Tx date 2021-02-03 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,296
+83,000 vol $0.1843 each |
1,255,096 | |
Filed 2021-02-02 15:57 Tx date 2021-02-02 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,280
+32,000 vol $0.165 each |
1,172,096 | |
Filed 2021-01-28 12:52 Tx date 2021-01-27 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
$56,000
+350,000 vol $0.16 each |
1,140,096 | |
Filed 2021-01-28 12:50 Tx date 2021-01-27 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$-56,000
-350,000 vol $0.16 each |
2,356,904 | |
Filed 2021-01-22 15:30 Tx date 2021-01-22 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$300.00
+2,000 vol $0.15 each |
790,096 | |
Filed 2021-01-20 16:27 Tx date 2021-01-20 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$310.00
+2,000 vol $0.155 each |
2,706,904 | |
Filed 2020-12-18 15:46 Tx date 2020-12-18 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,400
+10,000 vol $0.14 each |
2,704,904 | |
Filed 2020-12-15 14:55 Tx date 2020-12-15 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,960
+15,000 vol $0.1307 each |
2,694,904 | |
Filed 2020-12-09 14:43 Tx date 2020-12-09 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,380
+26,000 vol $0.13 each |
2,679,904 | |
Filed 2020-12-01 17:56 Tx date 2020-12-01 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,325
+25,000 vol $0.133 each |
2,653,904 | |
Filed 2020-11-19 12:55 Tx date 2020-11-18 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$240.00
+2,000 vol $0.12 each |
2,628,904 | |
Filed 2020-11-13 15:19 Tx date 2020-11-12 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$250.00
+2,000 vol $0.125 each |
2,626,904 | |
Filed 2020-10-18 17:19 Tx date 2020-10-05 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-37,500
-250,000 vol $0.15 each |
500,000 | |
Filed 2020-10-18 17:06 Tx date 2020-10-05 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$37,500
+250,000 vol $0.15 each |
2,624,904 | |
Filed 2020-09-16 19:23 Tx date 2020-09-15 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$22,500
+150,000 vol $0.15 each |
788,096 | |
Filed 2020-09-16 19:20 Tx date 2020-09-15 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-22,500
-150,000 vol $0.15 each |
1,000,000 | |
Filed 2020-08-31 15:24 Tx date 2020-08-31 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$205.00
+1,000 vol $0.205 each |
2,374,904 | |
Filed 2020-08-24 17:55 Tx date 2020-08-21 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$480.00
+2,000 vol $0.24 each |
2,373,904 | |
Filed 2020-08-19 15:59 Tx date 2020-08-19 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$205.00
+1,000 vol $0.205 each |
2,371,904 | |
Filed 2020-08-19 15:58 Tx date 2020-08-18 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$975.00
+5,000 vol $0.195 each |
2,370,904 | |
Filed 2020-08-18 00:39 Tx date 2020-08-17 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,500
+17,500 vol $0.20 each |
2,365,904 | |
Filed 2020-08-13 01:50 Tx date 2020-08-12 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$440.00
+2,000 vol $0.22 each |
2,348,404 | |
Filed 2020-04-14 17:11 Tx date 2019-09-20 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
-375,000 vol |
750,000 | |
Filed 2020-04-13 19:45 Tx date 2020-04-13 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-425,000 vol |
1,150,000 | |
Filed 2020-04-13 18:55 Tx date 2019-12-31 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+750,000 vol |
1,575,000 | |
Filed 2020-02-07 16:47 Tx date 2020-02-07 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$50,000
+238,096 vol $0.21 each |
638,096 | |
Filed 2020-02-07 16:43 Tx date 2020-02-07 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
97 - Other
|
$-50,000.16
-238,096 vol $0.21 each |
2,346,404 | |
Filed 2019-12-22 17:33 Tx date 2019-12-13 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$15,000
+50,000 vol $0.30 each |
50,000 | |
Filed 2019-12-22 17:25 Tx date 2019-12-13 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$30,000
+100,000 vol $0.30 each |
400,000 | |
Filed 2019-10-01 14:25 Tx date 2019-09-20 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$45,000
+300,000 vol $0.15 each |
300,000 | |
Filed 2019-10-01 14:22 Tx date 2017-06-15 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-08-15 15:18 Tx date 2019-08-13 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$410.10
+3,000 vol $0.1367 each |
2,584,500 | |
Filed 2019-06-26 20:24 Tx date 2019-06-26 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$225.00
+1,500 vol $0.15 each |
2,581,500 | |
Filed 2019-06-26 20:23 Tx date 2019-06-26 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$507.50
+3,500 vol $0.145 each |
2,580,000 | |
Filed 2019-06-21 19:52 Tx date 2019-06-18 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$75,000
+500,000 vol $0.15 each |
2,576,500 | |
Filed 2019-06-07 14:41 Tx date 2019-06-07 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$500.00
+5,000 vol $0.10 each |
2,076,500 | |
Filed 2019-04-20 18:28 Tx date 2019-04-16 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+500,000 vol |
1,125,000 | |
Filed 2019-04-20 18:16 Tx date 2019-04-16 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$50,000
+500,000 vol $0.10 each |
2,071,500 | |
Filed 2019-03-07 Tx date 2019-03-07 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$450.00
+10,000 vol $0.045 each |
1,571,500 | |
Filed 2019-03-06 Tx date 2019-03-05 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$450.00
+10,000 vol $0.045 each |
1,561,500 | |
Filed 2019-03-04 Tx date 2019-03-04 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$600.00
+12,000 vol $0.05 each |
1,551,500 | |
Filed 2019-02-19 Tx date 2019-02-19 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$150.00
+3,000 vol $0.05 each |
1,539,500 | |
Filed 2019-02-18 Tx date 2019-02-14 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$350.00
+7,000 vol $0.05 each |
1,536,500 | |
Filed 2019-02-01 Tx date 2019-01-31 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,350
+30,000 vol $0.045 each |
1,529,500 | |
Filed 2018-12-31 Tx date 2018-12-28 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,350
+30,000 vol $0.045 each |
1,499,500 | |
Filed 2018-10-09 Tx date 2017-06-15 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-10-09 Tx date 2018-10-05 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$50,000
+500,000 vol $0.10 each |
1,469,500 | |
Filed 2018-10-09 Tx date 2018-10-04 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$50,000
+500,000 vol $0.10 each |
||
Filed 2018-10-09 Tx date 2017-09-20 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+375,000 vol |
||
Filed 2018-10-09 Tx date 2018-10-05 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+250,000 vol |
625,000 | |
Filed 2018-10-09 Tx date 2017-09-20 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+375,000 vol |
375,000 | |
Filed 2018-10-09 Tx date 2018-10-04 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+250,000 vol |
||
Filed 2018-10-09 Tx date 2018-10-05 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$50,000
+500,000 vol $0.10 each |
||
Filed 2018-10-08 Tx date 2018-10-05 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$50,000
+500,000 vol $0.10 each |
1,469,500 | |
Filed 2018-10-02 Tx date 2018-10-01 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,500
+30,000 vol $0.05 each |
969,500 | |
Filed 2017-10-02 Tx date 2017-06-15 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-10-02 Tx date 2017-09-20 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$75,000
+750,000 vol $0.10 each |
939,500 | |
Filed 2017-10-02 Tx date 2017-06-15 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Holder: GRG CONSULTING LTD (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
189,500 | ||
Filed 2017-10-02 Tx date 2017-09-20 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+375,000 vol |
375,000 | |
Filed 2017-10-01 Tx date 2017-06-15 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$37,500
+250,000 vol $0.15 each |
||
Filed 2017-10-01 Tx date 2017-09-15 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,500
+150,000 vol $0.15 each |
||
Filed 2017-10-01 Tx date 2017-06-15 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
675,000 | |
Filed 2017-10-01 Tx date 2017-09-15 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
825,000 | |
Filed 2017-10-01 Tx date 2017-06-15 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-10-01 Tx date 2017-06-15 |
$BUX
Biomark Diagnostics Inc. |
HUANG, GUOYU
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
425,000 |